Axem Announces First Members of Scientific Advisory Board

Axem Neurotechnology Inc., a company on a mission to revolutionize stroke recovery, is thrilled to announce the first members of it’s Scientific Advisory Board (SAB). This monumental step symbolizes Axem's commitment to integrating cutting-edge scientific insights into its innovative post-stroke recovery solutions. The appointment of two distinguished members to the SAB marks a significant milestone in Axem's journey towards transforming neurological rehabilitation.

The first member of our Scientific Advisory Board is Dr. Carolee J. Winstein, PhD, PT. Dr. Winstein is a luminary in the field of stroke rehabilitation, widely recognized for her groundbreaking work. As the previous Chair of the American Stroke Association Guidelines for Adult Stroke Rehabilitation and Recovery, Dr. Winstein brings an unparalleled depth of knowledge and expertise. Her research, which focuses on neurorehabilitation and recovery mechanisms, has been instrumental in shaping contemporary stroke rehabilitation practices. Dr. Winstein's involvement with Axem will provide invaluable guidance, ensuring that our rehabilitation approaches are grounded in the most current and effective practices.

Joining Dr. Winstein is Dr. Steven C. Cramer, MD, a trailblazer in neuroimaging biomarkers for stroke recovery. Dr. Cramer's extensive research inspired many of Axem's core technologies. His pioneering work in understanding the brain's recovery mechanisms post-stroke has been widely published and cited, making him a revered figure in the neuroscience community. Dr. Cramer's expertise will be pivotal in ensuring that our solutions remain at the forefront of technological and clinical advancements.

The formation of the Scientific Advisory Board is a testament to Axem's dedication to excellence and innovation in stroke recovery. The combined expertise of Dr. Winstein and Dr. Cramer will provide Axem with unparalleled scientific guidance, enabling us to continue developing and refining our approaches to post-stroke care. Their insights will play a crucial role in our mission to redefine the landscape of neurological rehabilitation.

We are honored to have such esteemed professionals join our team and look forward to the profound impact their contributions will have on our journey ahead.

For further inquiries, please contact: Tony Ingram, CEO, at tony@axemneuro.com.